Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06575374

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Led by M.D. Anderson Cancer Center · Updated on 2026-01-21

36

Participants Needed

1

Research Sites

137 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical research study is to learn if a drug called Letermovir can help to prevent CMV reactivation.

CONDITIONS

Official Title

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • ECOG performance status of 0 or 1
  • Scheduled for standard of care axicabtagene ciloleucel (AXI-CEL) therapy
  • Seropositive for cytomegalovirus (CMV) as shown by anti-CMV IgG antibodies
  • Creatinine clearance greater than 10 mL/min
  • Child Pugh class A or B if liver disease is present
  • Agree to use effective contraception if of child-bearing potential
  • Understand and sign informed consent before any study procedures
Not Eligible

You will not qualify if you...

  • Uncontrolled illness including active infections not responding to treatment, heart failure, unstable angina, arrhythmia, or psychiatric/social issues limiting study compliance
  • Pregnant or breastfeeding women
  • Unable or unwilling to follow study requirements
  • Planned treatment with high-dose anti-CMV drugs such as acyclovir or valacyclovir for CMV prevention
  • Any condition making the participant unsuitable for study drug as judged by the Investigator
  • Evidence of CMV infection within 1 week before starting Letermovir
  • Child Pugh class C liver disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MD Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

G

George Chen, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here